Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Garofalo

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
European Heart Journal. Imaging Methods and Practice|September 3, 2024
Assessing cardiac mechanics through left ventricular haemodynamic forcesAlberto Aimo, Giorgia Panichella, Iacopo Fabiani, et al.
Heart and Vessels|April 28, 2026
Response to Letters on "Long-term outcome of tailored antithrombotic therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a 5-year retrospective cohort study"Emanuele Cecchi, Andrea Grasso Granchietti, Claudia Assenza, et al.
International Journal of Cardiology|January 13, 2025
Left atrial strain and risk of atrial fibrillation after coronary artery bypass-graftingAndrea Grasso Granchietti, Niccolò Ciardetti, Carlotta Mazzoni, et al.
Journal of Clinical Medicine|July 29, 2023
The Role of Multimodality Imaging in Pediatric CardiomyopathiesSara Moscatelli, Isabella Leo, Francesco Bianco, et al.
Heart and Vessels|August 21, 2025
Long-term outcome of tailored antithrombotic therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a 5-year retrospective cohort studyEmanuele Cecchi, Andrea Grasso Granchietti, Claudia Assenza, et al.
International Journal of Cardiology|January 14, 2026
Non-invasive evaluation of left ventricular hemodynamic force abnormalities in hypertrophic cardiomyopathy: Implications for myosin inhibitionChiara Zocchi, Alessandra Milazzo, Giorgia Panichella, et al.
JACC. Advances|April 26, 2025
Genotype-Negative Patients With Familial Hypertrophic Cardiomyopathy: Traveling to the "Middle Earth"Francesca Bonanni, Annamaria Del Franco, Valeria Setti, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 28, 2025
Cardiovascular Safety of Bruton Tyrosine Kinase Inhibitors: From Ibrutinib to Next-Generation AgentsLuigi Spadafora, Federico Russo, Ewelina Bukowska-Olech, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 19, 2026
Evolving Epidemiology of Cardiomyopathies at a National Referral Centre: a 30-Year Longitudinal StudyFederica Colio, Annamaria Del Franco, Alessia Argirò, et al.
European Heart Journal. Digital Health|September 23, 2025
Artificial intelligence applications in hypertrophic cardiomyopathy: turns and loopholesGiorgia Panichella, Manuel Garofalo, Laura Sasso, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Heart Journal. Imaging Methods and Practice|September 3, 2024
Assessing cardiac mechanics through left ventricular haemodynamic forcesAlberto Aimo, Giorgia Panichella, Iacopo Fabiani, et al.
Heart and Vessels|April 28, 2026
Response to Letters on "Long-term outcome of tailored antithrombotic therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a 5-year retrospective cohort study"Emanuele Cecchi, Andrea Grasso Granchietti, Claudia Assenza, et al.
International Journal of Cardiology|January 13, 2025
Left atrial strain and risk of atrial fibrillation after coronary artery bypass-graftingAndrea Grasso Granchietti, Niccolò Ciardetti, Carlotta Mazzoni, et al.
Journal of Clinical Medicine|July 29, 2023
The Role of Multimodality Imaging in Pediatric CardiomyopathiesSara Moscatelli, Isabella Leo, Francesco Bianco, et al.
Heart and Vessels|August 21, 2025
Long-term outcome of tailored antithrombotic therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a 5-year retrospective cohort studyEmanuele Cecchi, Andrea Grasso Granchietti, Claudia Assenza, et al.
International Journal of Cardiology|January 14, 2026
Non-invasive evaluation of left ventricular hemodynamic force abnormalities in hypertrophic cardiomyopathy: Implications for myosin inhibitionChiara Zocchi, Alessandra Milazzo, Giorgia Panichella, et al.
JACC. Advances|April 26, 2025
Genotype-Negative Patients With Familial Hypertrophic Cardiomyopathy: Traveling to the "Middle Earth"Francesca Bonanni, Annamaria Del Franco, Valeria Setti, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 28, 2025
Cardiovascular Safety of Bruton Tyrosine Kinase Inhibitors: From Ibrutinib to Next-Generation AgentsLuigi Spadafora, Federico Russo, Ewelina Bukowska-Olech, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 19, 2026
Evolving Epidemiology of Cardiomyopathies at a National Referral Centre: a 30-Year Longitudinal StudyFederica Colio, Annamaria Del Franco, Alessia Argirò, et al.
European Heart Journal. Digital Health|September 23, 2025
Artificial intelligence applications in hypertrophic cardiomyopathy: turns and loopholesGiorgia Panichella, Manuel Garofalo, Laura Sasso, et al.
Pageof 3